Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added, replacing the previous v3.5.3. This indicates a small update to the page's versioning history.
    Difference
    0.1%
    Check dated 2026-05-15T02:11:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed.
    Difference
    0.1%
    Check dated 2026-04-30T16:34:10.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The history now shows a new revision v3.5.2 added and the previous v3.5.0 revision removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:12:58.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history. Removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T18:05:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the Record History and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:35.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.2, was added to the record history, and the government funding notice banner was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T10:24:20.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.